BSECompany Update5 Nov 2026 · 5 Nov 2026, 09:31 pm

Wholly Owned Subsidiary of the Company namely 'Eiko Scientific Solutions LLP' (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources Private Limited. The private limited company will be incorporated as a joint venture between Oval Projects Engineering Limited and Eiko Scientific Solutions LLP, with each holding 50% of share capital.

Eiko Lifesciences Ltd · 540204

✦ AI SummaryJoint Venture

Eiko Lifesciences Ltd's wholly owned subsidiary, Eiko Scientific Solutions LLP, is proposed to enter into a joint venture with Oval Projects Engineering Limited to form a new private limited company, Oval Eiko Resources Private Limited, with each holding 50% of the share capital.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Restructuring

Attachments (1)

📄

ae07889c-9035-4846-b76a-5c2f97c98de8.pdf

pdf

Download →
View document text
Date: 05th November, 2026 Corporate Services Department BSE Limited Phiroze Jeejeebhoy Towers, 1st Floor, Dalal Street, Fort, Mumbai – 400001 Scrip Code: 540204 Subject: Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Proposed Incorporation of a Private Limited Company by way of Joint Venture by Wholly Owned Subsidiary Dear Sir/ Madam, We wish to inform that the Wholly Owned Subsidiary of the Company namely “Eiko Scientific Solutions LLP” (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources Private Limited. The private limited company will be incorporated as a joint venture between Oval Projects Engineering Limited and Eiko Scientific Solutions LLP, with each holding 50% of share capital. Disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 and other applicable circulars, if any, is enclosed herewith as “Annexure A”. Kindly take the above on record and oblige. For Eiko LifeSciences Limited Chintan Doshi Company Secretary and Compliance Officer Membership No: ACS 36190 Encl. As Above Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com Annexure – A Acquisition of ‘to be incorporated’ companies: Particular Details Name of the entity, date & country of Name: Oval Eiko Resources Private Limited incorporation, etc. Date: Name Approval from MCA received on 23/10/2026 Country of Incorporation: India Name of holding company of the Eiko Scientific Solutions LLP shall be holding incorporated company and relation with the 50% of the Share Capital in the Proposed listed entity Company (to be formed as a 50-50 Joint Venture Between Eiko Scientific Solutions LLP and Oval Projects Engineering Limited) Eiko Scientific Solutions LLP is wholly owned Subsidiary of the Listed Entity. Industry to which the entity being Renewable Energy: Compressed Bio Gas incorporated belongs Production and Distribution Brief background about the entity Oval Eiko Resources Private Limited will be incorporated in terms of products / line of into Renewable Energy and Compressed Bio business Gas Production and Distribution. Broad Business Activities : Renewable Energy: Compressed Bio Gas, Condensation stabilization Unit or Industrial Fuel and chemical unit, Essential oil Unit, Engineered wood unit, etc. Brief details of any government or Regulatory NA approval required for the acquisition. Nature of consideration - whether cash Cash Consideration consideration or share swap and details of the same; Cost of subscription / price at which the Rs. 2,50,000/- (initial proposed Capital) shares are subscribed Eiko Scientific Solutions LLP will subscribe 50% of the Total Share Capital i.e. 25000 Equity Shares of Rs. 10 each. percentage of shareholding / control by the Eiko Scientific Solutions LLP is wholly owned listed entity and / or number of shares Subsidiary of Eiko Lifesciences Ltd. (Listed allotted Entity). 99.99 % Shares are held by the Listed Entity and 0.01% Shares are held by Nominee of the Listed Entity. Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com